keyword
https://read.qxmd.com/read/39259554/the-villanelle-as-oncology-rounds
#1
JOURNAL ARTICLE
Rafael Campo
No abstract text is available yet for this article.
September 11, 2024: JAMA
https://read.qxmd.com/read/39259509/successful-treatment-of-trichilemmal-carcinoma-with-distant-metastasis-using-pembrolizumab-a-case-report-and-review
#2
REVIEW
Lei Liu, Tengfei Long, Nannan Wei, Hongyan Zhang, Chaoliang Tang, Jin Gao
Trichilemmal carcinoma (TC) is a rare, malignant cutaneous adnexal tumor. TC often has nonspecific clinical manifestations and its aggressive nature is frequently overlooked. Metastasis of TC is rarely reported and there is no standard treatment for recurrent or metastatic TC. We report a complicated case of TC arising from the parotid gland with metastasis to cervical lymph nodes. The tumor progressed after multiple surgeries, radiation and chemotherapy. Finally, the patient achieved good response and disease control with pembrolizumab, an immune checkpoint inhibitor targeting programmed cell death protein-1...
2024: Immunotherapy
https://read.qxmd.com/read/39259476/the-trend-of-the-treatment-of-advanced-hepatocellular-carcinoma-combination-of-immunotherapy-and-targeted-therapy
#3
REVIEW
Heng Dong, Zhengguo Zhang, Mengjie Ni, Xiaoyun Xu, Yifeng Luo, Yaru Wang, Haiyun Zhang, Jianxiang Chen
Hepatocellular carcinoma (HCC) is a common type of tumor worldwide. The development of systemic treatment of advanced HCC has remained stagnant for a considerable period. During the last years, a series of new treatment regimens based on the combination of immunotherapeutic drugs and targeted drugs have been gradually developed, increased the objective response rate (ORR), overall survival (OS), and progression free survival (PFS) of HCC patients. Among the different combination therapy groups, atezolizumab plus bevacizumab and sintilimab plus IBI-305 seem to have unique advantages, while head-to-head comparisons are still needed...
September 11, 2024: Current Treatment Options in Oncology
https://read.qxmd.com/read/39259454/does-circulating-tumor-dna-apply-as-a-reliable-biomarker-for-the-diagnosis-and-prognosis-of-head-and-neck-squamous-cell-carcinoma
#4
REVIEW
Negin Ghiyasimoghaddam, Navidreza Shayan, Hanieh Alsadat Mirkatuli, Mohammadhasan Baghbani, Nima Ameli, Zeynab Ashari, Nooshin Mohtasham
Oral cavity cancer is the most common type of head and neck cancer. There is no definitive standard diagnosis, prognosis, or treatment response biomarker panel based on simple, specific, non-invasive, and reliable methods for head and neck squamous cell carcinoma (HNSCC) patients. On the other hand, the frequent post-treatment biopsies make it challenging to discriminate residual disease or recurrent tumors following postoperative reparative and post-radiation changes. Saliva, blood plasma, and serum samples were commonly used to monitor HNSCC through liquid biopsies...
September 11, 2024: Discover. Oncology
https://read.qxmd.com/read/39259412/the-sirt1-nrf2-pathway-is-a-key-factor-for-drug-therapy-in-chemotherapy-induced-cardiotoxicity-a-mini-review
#5
REVIEW
Suleiman Ibrahim Shelash Mohammad, Asokan Vasudevan, Felix Oghenemaro Enwa, Jaya Bansal, Mamata Chahar, Mamdouh Eldesoqui, Muhammad Ikram Ullah, Zhanna R Gardanova, Hanen Mahmod Hulail, Ahmed Hussein Zwamel
The likelihood of survival for cancer patients has greatly improved due to chemotherapy medicines. However, these antitumor agents might also have unfavorable effects on the cardiovascular system, which could result in sudden or gradual cardiac failure. The production of free radicals that result in oxidative stress appears to be the key mechanism by which chemotherapy-induced cardiotoxicity (CIC) happens. Reports suggest that the Sirtuin-1 (Sirt1)/Nuclear factor E2-associated factor 2 (Nrf2) signaling pathway has been considered an alternative path for counteracting cardiotoxicity by suppressing oxidative stress, inflammation, and apoptosis...
September 11, 2024: Medical Oncology
https://read.qxmd.com/read/39259411/predictive-value-of-perilesional-edema-volume-in-melanoma-brain-metastasis-response-to-stereotactic-radiosurgery
#6
JOURNAL ARTICLE
Mariya Yavorska, Miriam Tomiciello, Sciurti Antonio, Elisa Cinelli, Giovanni Rubino, Armando Perrella, Alfonso Cerase, Pierpaolo Pastina, Giovanni Luca Gravina, Silvia Arcieri, Maria Antonietta Mazzei, Giuseppe Migliara, Valentina Baccolini, Francesco Marampon, Giuseppe Minniti, Anna Maria Di Giacomo, Paolo Tini
BACKGROUND AND AIM: Stereotactic radiotherapy (SRT) is an established treatment for melanoma brain metastases (MBM). Recent evidence suggests that perilesional edema volume (PEV) might compromise the delivery and efficacy of radiotherapy to treat BM. This study investigated the association between SRT efficacy and PEV extent in MBM. MATERIALS AND METHODS: This retrospective study reviewed medical records from January 2020 to September 2023. Patients with up to 5 measurable MBMs, intracranial disease per RANO/iRANO criteria, and on low-dose corticosteroids were included...
September 11, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/39259399/developing-a-national-study-that-integrates-the-geriatric-assessment-into-the-care-of-older-patients-with-myeloid-malignancies
#7
REVIEW
Vijaya Raj Bhatt
PURPOSE OF REVIEW: To highlight the priorities in geriatric assessment research in myeloid malignancies and discuss design considerations necessary to ensure research is patient-centric, generalizeable, and high quality. RECENT FINDINGS: Older adults with myeloid malignancies including those who are perceived to have excellent performance status have multiple functional impairments. These impairments are associated with early mortality. Older adults have different functional trajectories through the course of treatment; this will be further investigated in our ongoing multicenter study...
September 11, 2024: Current Oncology Reports
https://read.qxmd.com/read/39259388/using-machine-learning-methods-to-investigate-the-impact-of-age-on-the-causes-of-death-in-patients-with-early-intrahepatic-cholangiocarcinoma-who-underwent-surgery
#8
JOURNAL ARTICLE
Shiqin Song, Shixiong Song, Huarong Zhao, Shike Huang, Xinghua Xiao, Xiaobo Lv, Yuehong Deng, Yiyin Tao, Yanlin Liu, Ke Su, Shansha Cheng
BACKGROUND: The impact of age on the causes of death (CODs) in patients with early-stage intrahepatic cholangiocarcinoma (ICC) who had undergone surgery was analyzed in this study. METHODS: A total of 1555 patients (885 in the older group and 670 in the younger group) were included in this study. Before and after applying inverse probability of treatment weighting (IPTW), the different CODs in the 2 groups were further investigated. Additionally, 7 different machine learning models were used as predictive tools to identify key variables, aiming to evaluate the therapeutic outcome in early ICC patients undergoing surgery...
September 11, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39259387/high-dose-vitamin-c-as-a-metabolic-treatment-of-cancer-a-new-dimension-in-the-era-of-adjuvant-and-intensive-therapy
#9
REVIEW
Xin Wang, Jia He, Minmin Sun, Shiwan Wang, Jinxiu Qu, Hanping Shi, Benqiang Rao
The anti-cancer mechanism of High-dose Vitamin C (HDVC) is mainly to participate in the Fenton reaction, hydroxylation reaction, and epigenetic modification, which leads to the energy crisis, metabolic collapse, and severe peroxidation stress that results in the proliferation inhibition or death of cancer cells. However, the mainstream view is that HDVC does not significantly improve cancer treatment outcomes. In clinical work and scientific research, we found that some drugs or therapies can significantly improve the anti-cancer effects of HDVC, such as PD-1 inhibitors that can increase the anti-cancer effects of cancerous HDVC by nearly three times...
September 11, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39259376/efficacy-and-tolerance-of-hyperthermic-intravesical-chemotherapy-hivec-according-to-the-number-of-instillations-administered
#10
MULTICENTER STUDY
Pierre-Etienne Gabriel, Géraldine Pignot, Michael Baboudjian, Cédric Lebacle, Alexandre Chamouni, Eric Lechevallier, Jacques Irani, Xavier Tillou, Thibaut Waeckel, Arnaud Monges, Jochen Walz, Gwenaelle Gravis, Céline Duperron, Xavier Carpentier, Clément Klein, Alexandra Masson-Lecomte
PURPOSE: To report the oncological outcomes and the tolerance between 6 instillations and more than 6 cycles of hyperthermic intravesical chemotherapy(HIVEC) in patients with non-muscle invasive bladder cancer(NMIBC). METHODS: This is a multicenter retrospective study from a national database including 9 expert centers. All patients treated with HIVEC between 2016 and 2023 for NMIBC were included. Patients were classified into two groups according to the total number of HIVEC instillations, including induction plus maintenance...
September 11, 2024: World Journal of Urology
https://read.qxmd.com/read/39259371/unmasking-disparities-in-gallbladder-cancer-outcomes-in-the-disaggregated-asian-american-population
#11
JOURNAL ARTICLE
Keshav Kooragayala, Michael Wang, Francis J Spitz, Tanay Veer Gandhi, John Dibato, Young Ki Hong
BACKGROUND: Gallbladder cancer (GBC) is associated with a high mortality rate. Asian American (AsA) are among the fastest-growing populations in the United States, yet little is known about the disparity of GBC within this cohort. This study identified trends in treatment and outcomes for GBC in a disaggregated fashion, specifically for this population. METHODS: A retrospective analysis of the National Cancer Database (NCDB) between 2010 and 2019 examining all patients treated for gallbladder cancer was performed...
September 11, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/39259370/identification-of-circadian-clock-related-immunological-prognostic-index-and-molecular-subtypes-in-prostate-cancer
#12
JOURNAL ARTICLE
Lu Che, Dengxiong Li, Jie Wang, Zhouting Tuo, Koo Han Yoo, Dechao Feng, Yun Ou, Ruicheng Wu, Wuran Wei
BACKGROUND: Evidence suggests that the circadian clock (CIC) is among the important factors for tumorigenesis. We aimed to provide new insights into CIC-mediated molecular subtypes and gene prognostic indexes for prostate cancer (PCa) patients undergoing radical prostatectomy (RP) or radical radiotherapy (RT). METHODS: PCa data from TCGA was analyzed to identify differentially expressed genes (DEGs) with significant fold changes and p-values. A prognostic index called CIC-related gene prognostic index (CICGPI) was developed through clustering methods and survival analysis and validated on multiple data sets...
September 11, 2024: Discover. Oncology
https://read.qxmd.com/read/39259360/the-risk-of-endocrine-interventions-in-carriers-of-a-genetic-predisposition-for-breast-and-gynecologic-cancers-recommendations-of-the-german-consortium-for-hereditary-breast-and-ovarian-cancer
#13
REVIEW
O Ortmann, S Schüler-Toprak, K Kast
PURPOSE: To support doctors in counselling women with genetic predisposition for breast or gynecologic cancers on endocrine interventions. METHODS: Evidence on the safety of endocrine interventions for fertility treatment, contraception, hormone replacement therapy after risk-reducing salpingo-oophorectomy (RRSO) or treatment of symptoms during peri- and postmenopause was analysed for carriers of probably pathogenic and pathogenic variants in BRCA1 or BRCA2 (BRCA1/2-pV), in other breast and ovarian cancer genes and the Lynch Syndrome...
September 11, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39259349/preclinical-monitoring-of-radiation-induced-brain-injury-via-glucest-mri-and-resting-state-fmri-at-7%C3%A2-t-an-exploratory-study-on-mri-guided-oar-avoidance
#14
JOURNAL ARTICLE
Guodong Li, Hao Li, Na Weng, Caiyun Liu, Xianglin Li, Qinglong Li, Li Bin, Kai Zhu, Danqi Huang, Jia Liu, Yan Liu, Xu Wang
PURPOSE: To assess the value of glutamate chemical exchange saturation transfer (GluCEST) after whole-brain radiotherapy (WBRT) as an imaging marker of radiation-induced brain injury (RBI) and to preliminarily show the feasibility of multiparametric MRI-guided organ at risk (OAR) avoidance. METHODS: Rats were divided into two groups: the control (CTRL) group (n = 9) and the RBI group (n = 9). The rats in the RBI group were irradiated with an X‑ray radiator and then subjected to a water maze experiment 4 weeks later...
September 11, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/39259348/allies-not-enemies-creating-a%C3%A2-more-empathetic-and-uplifting-patient-experience-through-technology-and-art
#15
REVIEW
Luca Tagliaferri, Bruno Fionda, Calogero Casà, Patrizia Cornacchione, Sara Scalise, Silvia Chiesa, Elisa Marconi, Loredana Dinapoli, Beatrice Di Capua, Daniela Pia Rosaria Chieffo, Fabio Marazzi, Vincenzo Frascino, Giuseppe Ferdinando Colloca, Vincenzo Valentini, Francesco Miccichè, Maria Antonietta Gambacorta
OBJECTIVE: To understand whether art and technology (mainly conversational agents) may help oncology patients to experience a more humanized journey. METHODS: This narrative review encompasses a comprehensive examination of the existing literature in this field by a multicenter, multidisciplinary, and multiprofessional team aiming to analyze the current developments and potential future directions of using art and technology for patient engagement...
September 11, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/39259338/ct-and-mr-imaging-characteristics-of-primary-hepatic-lymphoma
#16
JOURNAL ARTICLE
Yaodan Zhang, Jianmin Cui, Zhaoxiang Ye, Xubin Li
BACKGROUND: Primary hepatic lymphoma (PHL) is a rare primary liver tumor. The purpose of this study was to investigate the crucial imaging characteristics of PHL. METHODS: CT/MR data and clinical features of 16 patients with pathologically proven PHL were retrospectively reviewed. The assessed imaging characteristics included lesion distribution, growth appearance, density or signal characteristics, and typical signs during the dynamic enhancement. RESULTS: A total of sixteen patients were included in this study, ranging in age from 27 to 86 years (nine men and seven women; mean age, 62 years)...
September 11, 2024: Discover. Oncology
https://read.qxmd.com/read/39259333/kif18b-an-important-role-in-signaling-pathways-and-a-potential-resistant-target-in-tumor-development
#17
REVIEW
Shicheng Chen, Bo Yu, Guo Tu DU, Tian Yu Huang, Neng Zhang, Ni Fu
KIF18B is a key member of the kinesin-8 family, involved in regulating various physiological processes such as microtubule length, spindle assembly, and chromosome alignment. This article briefly introduces the structure and physiological functions of KIF18B, examines its role in malignant tumors, and the associated carcinogenic signaling pathways such as PI3K/AKT, Wnt/β-catenin, and mTOR pathways. Research indicates that the upregulation of KIF18B enhances tumor malignancy and resistance to radiotherapy and chemotherapy...
September 11, 2024: Discover. Oncology
https://read.qxmd.com/read/39259325/pmda-regulatory-update-on-approval-and-revision-of-the-precautions-for-use-of-anticancer-drugs-approval-of-alectinib-and-pembrolizumab-for-the-adjuvant-treatment-of-non-small-cell-lung-cancer-in-japan
#18
EDITORIAL
Noriomi Matsumura, Masaki Mandai
No abstract text is available yet for this article.
September 11, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/39259324/defining-the-clinical-benefits-of-adding-a-neurokinin-1-receptor-antagonist-to-control-chemotherapy-induced-nausea-and-vomiting-in-moderately-emetogenic-chemotherapy-a-systematic-review-and-meta-analysis-of-the-clinical-practice-guidelines-for-antiemesis-2023
#19
JOURNAL ARTICLE
Toshinobu Hayashi, Shun Yamamoto, Yoshiharu Miyata, Masayuki Takeda, Masakazu Abe, Makoto Wada, Keiko Iino, Tatsuo Akechi, Chiyo K Imamura, Ayako Okuyama, Keiko Ozawa, Yong-Il Kim, Hidenori Sasaki, Eriko Satomi, Ryuhei Tanaka, Takako Eguchi Nakajima, Naoki Nakamura, Junichi Nishimura, Mayumi Noda, Kazumi Hayashi, Takahiro Higashi, Narikazu Boku, Koji Matsumoto, Yoko Matsumoto, Kenji Okita, Nobuyuki Yamamoto, Kenjiro Aogi, Hirotoshi Iihara
BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) commonly affects patient quality of life and the overall effectiveness of chemotherapy. This study aimed to evaluate whether adding neurokinin-1 receptor antagonists (NK1RAs) to 5-hydroxytryptamine-3 receptor antagonists (5-HT3 RAs) and corticosteroids provides clinically meaningful benefits in preventing CINV in patients receiving moderately emetogenic chemotherapy (MEC). METHODS: We conducted a systematic review of PubMed, Cochrane Library, and Ichushi-Web to identify clinical studies evaluating NK1RAs combined with 5-HT3 RAs and dexamethasone for managing CINV in MEC...
September 11, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/39259304/cryotherapy-versus-radical-prostatectomy-as-a-salvage-treatment-for-radio-recurrent-prostate-cancer
#20
MULTICENTER STUDY
Juan Gomez Rivas, Mark Taratkin, Camilla Azilgareeva, Andrey Morozov, Silvia Laso, Dmitry Enikeev, Jesús Moreno Sierra, Ksenia Schelkunova, Francesco Sanguedolce, Alberto Breda, Alexander Govorov, Alexander Vasilyev, Marcos Cepeda, Lukas Lusuardi, Maximilian Pallauf, Antonio Celia, Tommaso Silvestri, Cristian Fiori, Esaú Fernández, Juan Ignacio Martínez-Salamanca, Eric Barret
INTRODUCTION: The aim of this study is to compare outcomes of SRP (salvage radical prostatectomy) with SCAP (salvage cryoablation of the prostate) in local radio-recurrent PCa (prostate cancer) patients. MATERIALS AND METHODS: A retrospective analysis of a multicentric European Society of Uro-technology (ESUT) database was performed. Data on patients with local recurrent PCa after radiotherapy who underwent salvage treatment were collected. Patients and their respective disease characteristics, perioperative complications as well as oncological outcomes were then described...
September 11, 2024: World Journal of Urology
keyword
keyword
516
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.